Temsirolimus (Torisel) For Advanced Kidney Cancer
The Food and Drug Administration (FDA) has approved temsirolimus (Torisel, Wyeth) for the treatment of advanced kidney cancer. In a clinical trial of 626 patients, one group received the study drug alone, another received a comparator agent (interferon alfa), and the third group received a combination of the two. The temsirolimus-alone group showed a significant [...]
Read User's Comments